Distinct histopathological phenotypes of severe alcoholic hepatitis suggest different mechanisms driving liver injury and failure
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Intrahepatic neutrophil infiltration has been implicated in severe alcoholic hepatitis (SAH) pathogenesis; however, the mechanism underlying neutrophil-induced injury in SAH remains obscure. This translational study aims to describe the patterns of intrahepatic neutrophil infiltration and its involvement in SAH pathogenesis. Immunohistochemistry analyses of explanted livers identified two SAH phenotypes despite a similar clinical presentation, one with high intrahepatic neutrophils (Neuhi), but low levels of CD8+ T cells, and vice versa. RNA-Seq analyses demonstrated that neutrophil cytosolic factor 1 (NCF1), a key factor in controlling neutrophilic ROS production, was upregulated and correlated with hepatic inflammation and disease progression. To study specifically the mechanisms related to Neuhi in AH patients and liver injury, we used the mouse model of chronic-plus-binge ethanol feeding and found that myeloid-specific deletion of the Ncf1 gene abolished ethanol-induced hepatic inflammation and steatosis. RNA-Seq analysis and the data from experimental models revealed that neutrophilic NCF1-dependent ROS promoted alcoholic hepatitis (AH) by inhibiting AMP-activated protein kinase (a key regulator of lipid metabolism) and microRNA-223 (a key antiinflammatory and antifibrotic microRNA). In conclusion, two distinct histopathological phenotypes based on liver immune phenotyping are observed in SAH patients, suggesting a separate mechanism driving liver injury and/or failure in these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures











Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“our previous data revealed that intrahepatic CD8+ T cells negatively correlated with hepatic neutrophils and liver injury markers.17”
From Opposite regulation of intestinal and intrahepatic CD8 + T cells controls alcohol-associated liver disease progression (2025) · cites this paper as [17]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fiji: an open-source platform for biological-image analysis
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890 · cited 2×
“Acquired images were processed and analyzed using FIJI (53), Ilastik”
Influentialilastik: interactive machine learning for (bio)image analysis
Berg, S., Kutra, D., Kroeger, T., Straehle, C. N., Kausler, B. X., Haubold, C., Schiegg, M., Ales, J., Beier, T., Rudy, M., et al. (2019) · Nature Methods · doi:10.1038/s41592-019-0582-9 · Cited by 3,368 · cited 1×
“3post3) (54), and CellProfiler (version 4.”
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Cantó, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., Elliott, P. J., Puigserver, P., & Auwerx, J. (2009) · Nature · doi:10.1038/nature07813 · Cited by 3,300 · cited 2×
“NAD+-dependent deacetylase SIRT1 regulates hepatocyte lipid synthesis through AMPK activation (35, 36).”
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
Gao, B., & Bataller, R. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.09.002 · Cited by 1,963
Self-citationMouse model of chronic and binge ethanol feeding (the NIAAA model)
Bertola, A., Mathews, S., Ki, S. H., Wang, H., & Gao, B. (2013) · Nature Protocols · doi:10.1038/nprot.2013.032 · Cited by 1,213 · cited 1×
“To specifically study the mechanism of how high levels of intrahepatic neutrophils cause liver injury in patients with AH, we used the mouse model of chronicplus-binge alcohol feeding, known to be associated with high intrahepatic neutrophils (25, 34).”
Self-citationCrabb, D. W., Im, G. Y., Szabo, G., Mellinger, J. L., & Lucey, M. R. (2020) · Hepatology · doi:10.1002/hep.30866 · Cited by 922
AMPK and SIRT1: a long-standing partnership?
Ruderman, N. B., Julia Xu, X., Nelson, L., Cacicedo, J. M., Saha, A. K., Lan, F., & Ido, Y. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00745.2009 · Cited by 903 · cited 1×
“Moreover, a substantial body of evidence suggests that upregulated SIRT1 can cause activation of AMPK through LKB1 in several types of tissues (47).”
SIRT1 Regulates Hepatocyte Lipid Metabolism through Activating AMP-activated Protein Kinase
Hou, X., Xu, S., Maitland-Toolan, K. A., Sato, K., Jiang, B., Ido, Y., Lan, F., Walsh, K., Wierzbicki, M., Verbeuren, T. J., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802187200 · Cited by 778 · cited 1×
“NAD+-dependent deacetylase SIRT1 regulates hepatocyte lipid synthesis through AMPK activation (35, 36).”
Self-citationNeutrophils as emerging therapeutic targets
Németh, T., Sperandio, M., & Mócsai, A. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0054-z · Cited by 653
MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases
Wang, X., He, Y., Mackowiak, B., & Gao, B. (2021) · Gut · doi:10.1136/gutjnl-2020-322526 · Cited by 495
Self-citationQuinn, M. T., & Gauss, K. A. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0404216 · Cited by 480
The role of AMP-activated protein kinase in the action of ethanol in the liver
You, M., Matsumoto, M., Pacold, C. M., Cho, W. K., & Crabb, D. W. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.049 · Cited by 469 · cited 3×
“Inhibition of AMPK by alcohol feeding has been shown to contribute to alcohol-induced hepatic steatosis (26).”
El-Benna, J., Dang, P. M.-C., Gougerot-Pocidalo, M.-A., Marie, J.-C., & Braut-Boucher, F. (2009) · Experimental and Molecular Medicine · doi:10.3858/emm.2009.41.4.058 · Cited by 446 · cited 2×
“As NCF1 is known to be expressed predominantly in neutrophils (24), the NCF1 effects we observed in myeloid-specific Ncf1-KO mice are mainly from neutrophils.”
A Histologic Scoring System for Prognosis of Patients With Alcoholic Hepatitis
Altamirano, J., Miquel, R., Katoonizadeh, A., Abraldes, J. G., Duarte–Rojo, A., Louvet, A., Augustin, S., Mookerjee, R. P., Michelena, J., Smyrk, T. C., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.018 · Cited by 421 · cited 1×
“We previously reported number is associated with better survival in AH patients (32, 41, 42).”
Self-citationDiagnosis and Treatment of Alcohol-Associated Liver Disease: A Review
Singal, A. K., & Mathurin, P. (2021) · JAMA · doi:10.1001/jama.2021.7683 · Cited by 398
Inflammatory pathways in alcoholic steatohepatitis
Gao, B., Ahmad, M. F., Nagy, L. E., & Tsukamoto, H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.023 · Cited by 392 · cited 2×
“This suggests that neutrophil-generated ROS is one of the mechanisms that contributes to liver injury and dysfunction in SAH in addition to many other cell types involved in SAH pathogenesis (12).”
Self-citationResveratrol alleviates alcoholic fatty liver in mice
Ajmo, J. M., Liang, X., Rogers, C. Q., Pennock, B., & You, M. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90358.2008 · Cited by 314
Mathurin, P., Duchatelle, V, Ramond, M., Degott, C., Bedossa, P., Erlinger, S., Benhamou, J., Chaput, J., Rueff, B., & Poynard, T. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8964410 · Cited by 292 · cited 1×
“We previously reported number is associated with better survival in AH patients (32, 41, 42).”
Bertola, A., Park, O., & Gao, B. (2013) · Hepatology · doi:10.1002/hep.26419 · Cited by 282 · cited 3×
“To further explore the mechanistic insight on the role of neutrophilic NCF1 in liver injury in patients with AH, we generated myeloid-specific Ncf1-KO (Ncf1Lyz–/–) mice and tested them in a mouse model of chronic-plusbinge ethanol feeding, a model known to be associated with significant intrahepatic neutrophil infiltr…”
Self-citationNeutrophils contribute to spontaneous resolution of liver inflammation and fibrosis via microRNA-223
Calvente, C. J., Tameda, M., Johnson, C. D., del Pilar, H., Lin, Y. C., Adronikou, N., De Mollerat Du Jeu, X., Llorente, C., Boyer, J., & Feldstein, A. E. (2019) · Journal of Clinical Investigation · doi:10.1172/jci122258 · Cited by 268 · cited 1×
“miR-223 has also been shown to block hepatic fibrosis (30, 48, 49).”
Dominguez, M., Miquel, R., Colmenero, J., Moreno, M., García–Pagán, J., Bosch, J., Arroyo, V., Ginès, P., Caballería, J., & Bataller, R. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.056 · Cited by 238
Self-citationLi, M., He, Y., Zhou, Z., Ramirez, T., Gao, Y., Gao, Y., Ross, R. A., Cao, H., Cai, Y., Xu, M., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-311861 · Cited by 229
Self-citationThe role of neutrophils in the development of liver diseases
Xu, R., Huang, H., Zhang, Z., & Wang, F.-S. (2014) · Cellular & Molecular Immunology · doi:10.1038/cmi.2014.2 · Cited by 226 · cited 1×
“Neutrophil dysfunction has been described not only in patients with AH, but also in those with cirrhosis (14, 15).”
Hou, X., Yin, S., Ren, R., Liu, S., Yong, L., Liu, Y., Li, Y., Zheng, M., Kunos, G., Gao, B., et al. (2021) · Hepatology · doi:10.1002/hep.31658 · Cited by 223 · cited 1×
“miR-223 has also been shown to block hepatic fibrosis (30, 48, 49).”
Self-citationSeo, W., Gao, Y., He, Y., Sun, J., Xu, H., Feng, D., Park, S. H., Cho, Y.-E., Guillot, A., Ren, T., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.06.018 · Cited by 218
Self-citationChang, B., Xu, M., Zhou, Z., Cai, Y., Li, M., Wang, W., Feng, D., Bertola, A., Wang, H., Kunos, G., et al. (2015) · Hepatology · doi:10.1002/hep.27921 · Cited by 210
Self-citationIn Vivo Neutrophil Dysfunction in Cirrhotic Patients with Advanced Liver Disease
Fiuza, C., Salcedo, M., Clemente, G., & Tellado, J. M. (2000) · The Journal of Infectious Diseases · doi:10.1086/315742 · Cited by 207 · cited 1×
“Neutrophil dysfunction has been described not only in patients with AH, but also in those with cirrhosis (14, 15).”
Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting
Avila, M. A., Dufour, J.-F., Gerbes, A. L., Zoulim, F., Bataller, R., Burra, P., Cortez-Pinto, H., Gao, B., Gilmore, I., Mathurin, P., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319720 · Cited by 206
Self-citationArgemi, J., Latasa, M. U., Atkinson, S. R., Blokhin, I. O., Massey, V., Gue, J. P., Cabezas, J., Lozano, J. J., Van Booven, D., Bell, A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11004-3 · Cited by 203 · cited 1×
“ated steatohepatitis patients were described previously (57).”
Self-citationA missense variant in NCF1 is associated with susceptibility to multiple autoimmune diseases
Zhao, J., Ma, J., Deng, Y., Kelly, J. A., Kim, K., Bang, S.-Y., Lee, H.-S., Li, Q.-Z., Wakeland, E. K., Qiu, R., et al. (2017) · Nature Genetics · doi:10.1038/ng.3782 · Cited by 183 · cited 1×
“Among all neutrophil-related signature genes, the NCF1 gene, encoding for the cytosolic 47 kDa phagocytic NADPH oxidase (p47phox) (31), plays an important role in controlling ROS production in neutrophils.”
Self-citationAn image analysis toolbox for high-throughput C. elegans assays
Wählby, C., Kamentsky, L., Liu, Z. H., Riklin-Raviv, T., Conery, A. L., O'Rourke, E. J., Sokolnicki, K. L., Visvikis, O., Ljosa, V., Irazoqui, J. E., et al. (2012) · Nature Methods · doi:10.1038/nmeth.1984 · Cited by 181
Bukong, T. N., Cho, Y., Iracheta-Vellve, A., Saha, B., Lowe, P., Adejumo, A., Furi, I., Ambade, A., Gyongyosi, B., Catalano, D., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.07.005 · Cited by 178
Interleukin‐22 Ameliorates Neutrophil‐Driven Nonalcoholic Steatohepatitis Through Multiple Targets
Hwang, S., He, Y., Xiang, X., Seo, W., Kim, S., Ma, J., Ren, T., Park, S. H., Zhou, Z., Feng, D., et al. (2020) · Hepatology · doi:10.1002/hep.31031 · Cited by 177 · cited 2×
“Hou X, et al. Myeloid-cell-specific IL-6 signaling promotes microRNA-223-enriched exosome production to attenuate NAFLD-associated fibrosis.”
Self-citationNeutrophils in liver diseases: pathogenesis and therapeutic targets
Liu, K., Wang, F.-S., & Xu, R. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00560-0 · Cited by 176 · cited 1×
“Mechanistically, neutrophils cause tissue injury by producing inflammatory mediators, proteases, and ROS (18).”
The Role of Lipid Metabolism in the Pathogenesis of Alcoholic and Nonalcoholic Hepatic Steatosis
Sozio, M., Liangpunsakul, S., & Crabb, D. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1267538 · Cited by 169 · cited 1×
“Once activated by phosphorylation, it stimulates energy-producing processes, such as fatty acid oxidation, and inhibits energy-utilizing processes, such as fatty acid synthesis (44).”
Self-citationHe, Y., Rodrigues, R. M., Wang, X., Seo, W., Ma, J., Hwang, S., Fu, Y., Trojnár, E., Mátyás, C., Zhao, S., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci141513 · Cited by 165
Self-citationFat-Specific Protein 27/CIDEC Promotes Development of Alcoholic Steatohepatitis in Mice and Humans
Xu, M.-J., Cai, Y., Wang, H., Altamirano, J., Chang, B., Bertola, A., Odena, G., Lu, J., Tanaka, N., Matsusue, K., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.06.009 · Cited by 145
Self-citationThe knowns and unknowns of treatment for alcoholic hepatitis
Sehrawat, T. S., Liu, M., & Shah, V. H. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30326-7 · Cited by 126
Super enhancer regulation of cytokine-induced chemokine production in alcoholic hepatitis
Liu, M., Cao, S., He, L., Gao, J., Arab, J. P., Cui, H., Xuan, W., Gao, Y., Sehrawat, T. S., Hamdan, F. H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24843-w · Cited by 120 · cited 1×
“A positive correlation among NCF1, intercellular adhesion molecule 1 ( ICAM1), and CXCL1 was observed with the trend in its correlation with IL6, TNFα, TNFAIP8, CCL2, and CXCL8 in patients with SAH (Figure 5D); this was reported to be associated with prognosis among AH patients (32, 33).”
Self-citationDas, S., Maras, J. S., Hussain, M. S., Sharma, S., David, P., Sukriti, S., Shasthry, S. M., Maiwall, R., Trehanpati, N., Singh, T. P., et al. (2017) · Hepatology · doi:10.1002/hep.28897 · Cited by 117 · cited 1×
“Neutrophil-induced oxidative stress and inflammation can be triggered by the oxidative modification of albumin found in patients with SAH (20).”
Current trials and novel therapeutic targets for alcoholic hepatitis
Singal, A. K., & Shah, V. H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.026 · Cited by 117
Alcoholic hepatitis: Translational approaches to develop targeted therapies
Mandrekar, P., Bataller, R., Tsukamoto, H., & Gao, B. (2016) · Hepatology · doi:10.1002/hep.28530 · Cited by 115 · cited 1×
“It has a high short-term mortality, especially in patients with severe forms of AH (SAH) (6, 7).”
Self-citationAlcohol‐Related Liver Disease: Areas of Consensus, Unmet Needs and Opportunities for Further Study†
Szabó, G., Kamath, P. S., Shah, V. H., Thursz, M. R., Mathurin, P., Addolorato, G., Bataller, R. A., Burra, P., Castéra, L., Cortez‐Pinto, H., et al. (2019) · Hepatology · doi:10.1002/hep.30369 · Cited by 113
Self-citationLin, C. –., Li, N., Cheng, H., & Yen, M. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13356 · Cited by 98 · cited 1×
“In addition, it has been well established that the expression and activity of SIRT1 can be suppressed by ROS in many cell types (45, 46), which is in agreement with our finding that SIRT1 expression was highly elevated in Ncf1Lyz–/– mice in the ALD model.”
Two Faces of Neutrophils in Liver Disease Development and Progression
Cho, Y., & Szabo, G. (2021) · Hepatology · doi:10.1002/hep.31680 · Cited by 97
Peeraphatdit, T. B., Kamath, P. S., Karpyak, V. M., Davis, B., Desai, V. S., Liangpunsakul, S., Sanyal, A. J., Chalasani, N., Shah, V. H., & Simonetto, D. A. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.04.048 · Cited by 94 · cited 1×
“However, in those with severe presentation, such as SAH, the disease is characterized by high short-term mortality (38) and early liver transplantation is required (39).”
Self-citationSingal, A. K., Arsalan, A., Dunn, W., Arab, J. P., Wong, R. J., Kuo, Y., Kamath, P. S., & Shah, V. H. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16461 · Cited by 89 · cited 10×
“Seo W, et al. ALDH2 deficiency promotes alcohol-associated liver cancer by activating oncogenic pathways via oxidized DNAenriched extracellular vesicles.”
InfluentialGuillot, A., Guerri, L., Feng, D., Kim, S.-J., Ahmed, Y. A., Paloczi, J., He, Y., Schuebel, K., Dai, S., Liu, F., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci132305 · Cited by 86
Self-citationGuillot, A., Kohlhepp, M., Bruneau, A., Heymann, F., & Tacke, F. (2020) · Cancers · doi:10.3390/cancers12092449 · Cited by 46
Self-citationWang, X., Seo, W., Park, S. H., Fu, Y., Hwang, S., Rodrigues, R. M., Feng, D., Gao, B., & He, Y. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.58365 · Cited by 44 · cited 1×
“miR-223 has also been shown to block hepatic fibrosis (30, 48, 49).”
Self-citationEarly liver transplantation for acute alcoholic hepatitis: We can’t say no
Mathurin, P. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.05.019 · Cited by 30
Hu, Y. W., Zhang, N., Fan, Q., Lin, M., Zhang, C., Fan, G., Zhai, X., Zhang, F., Chen, Z., & Yao, J. (2015) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2014-0513 · Cited by 23 · cited 1×
“In addition, it has been well established that the expression and activity of SIRT1 can be suppressed by ROS in many cell types (45, 46), which is in agreement with our finding that SIRT1 expression was highly elevated in Ncf1Lyz–/– mice in the ALD model.”
Current Management and Future Treatment of Alcoholic Hepatitis.
Mitchell, M. C., Kerr, T. A., & Herlong, H. F. (2020) · PubMed Central · Cited by 18
Clinical characteristics and outcomes of mild to moderate alcoholic hepatitis
Samala, N. R., Gawrieh, S., Tang, Q., Lourens, S. G., Shah, V. H., Sanyal, A. J., Liangpunsakul, S., & Chalasani, N. (2019) · GastroHep · doi:10.1002/ygh2.353 · Cited by 17 · cited 1×
“In mild cases, patients may improve with conservative management and have a favorable outcome (37).”
Self-citationPrognostic Value of Neutrophil-lymphocyte Ratio in Patients with Severe Alcoholic Hepatitis
Omar, Y. A., Randhawa, T., Attar, B. M., Agrawal, R., Wang, Y., Pichardo, R., Majeed, M., & Patel, S. A. (2019) · Cureus · doi:10.7759/cureus.6141 · Cited by 16 · cited 1×
“The ratio of neutrophils to lymphocytes has been reported to predict 90-day mortality of AH patients (13).”
Gougol, A., Clemente, A. P. G., Argemí, J., & Bataller, R. A. (2021) · Clinical Liver Disease · doi:10.1002/cld.1092 · Cited by 13 · cited 14×
“The volcano plot illustrated 503 up- and 186 downregulated hepatic genes in SAH patients when we compared the gene expression in patients with Neulo and those with Neuhi (Figure 3B).”
InfluentialSelf-citationPotts, J. R., Farahi, N., Howard, M. R., Taylor, M., Heard, S., Shankar, A., Alexander, G., Chilvers, E. R., Verma, S., & Peters, A. M. (2018) · Bioscience Reports · doi:10.1042/bsr20180466 · Cited by 8 · cited 1×
“The intervariability of neutrophil infiltration has also been reported in a study using 111In-leukocyte scintigraphy to image hepatic neutrophil migration in patients with AH (40).”
Cited by
Hepatic inflammatory responses in liver fibrosis
Hammerich, L., & Tacke, F. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00807-x · Cited by 803
“Neutrophil infiltration can be observed in all types of chronic liver disease, and they can contribute to hepatic inflammation through the production of inflammatory cytokines, activation of Kupffer cells and recruitment of other immune cells 90–93 .”
BackgroundSelf-citationAlcohol-associated liver disease
Mackowiak, B., Fu, Y., Maccioni, L., & Gao, B. (2024) · Journal of Clinical Investigation · doi:10.1172/jci176345 · Cited by 359
“This technique has been widely applied to investigate the tumor microenvironment and other types of liver disease but has only recently been utilized to interrogate the pathology of ALD (30, 31, 71).”
BackgroundMethodSelf-citationThe intersection between alcohol-related liver disease and nonalcoholic fatty liver disease
Díaz, L. A., Arab, J. P., Louvet, A., Bataller, R., & Arrese, M. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00822-y · Cited by 207
“Cellular events can occur in a sequential or parallel fashion, with variable intensity over time and within the spectrum of disease 178 .”
BackgroundSelf-citationImmune microenvironment in hepatocellular carcinoma: from pathogenesis to immunotherapy
Seyhan, D., Allaire, M., Fu, Y., Conti, F., Wang, X. W., Gao, B., & Lafdil, F. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01308-4 · Cited by 164
“The use of mIF has been successful in characterizing the TME in the context of various liver-associated diseases, including alcohol-associated hepatitis [311], necrotic liver formation [312], and liver aging [313].”
Self-citationGuillot, A., Winkler, M., Silva Afonso, M., Aggarwal, A., Lopez, D., Berger, H., Kohlhepp, M. S., Liu, H., Özdirik, B., Eschrich, J., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000270 · Cited by 116
“Therefore, we conducted multiplex immunostaining on liver samples from a wellcharacterized cohort of patients with AH (Figure 7B).[28] Remarkably, the general histological observations made on NASH and PSC samples, such as total, CK19+, IBA1+, or HepPar1+ cell distribution, also indicated the severity of AH (Figure 7C…”
BackgroundSelf-citation
Metadata
- Authors
- Ma, J., Guillot, A., Yang, Z., Mackowiak, B., Hwang, S., Park, O., Peiffer, B. J., Ahmadi, A. R., Melo, L., Kusumanchi, P., Huda, N., Saxena, R., He, Y., Guan, Y., Feng, D., Sancho-Bru, P., Zang, M., Cameron, A. M., Bataller, R., Tacke, F., Sun, Z., Liangpunsakul, S., & Gao, B.
- Affiliations
- National Institutes of Health (US)
- Indiana University Indianapolis (US)
- Johns Hopkins University (US)
- University of Pittsburgh Medical Center (US)
- Emory University (US)
- The University of Texas at San Antonio Health Science Center (US)
- Stiftung Charité (DE)
- Richard L. Roudebush VA Medical Center (US)
- Corresponding author
- Liangpunsakul, Suthat
- Gao, Bin
- ORCID
- Ma, Jing
- Guillot, Adrien
- Yang, Zhihong
- Mackowiak, Bryan
- Hwang, Seonghwan
- Peiffer, Brandon J.
- Ahmadi, Ali Reza
- Melo, Luma
- Kusumanchi, Praveen
- Huda, Nazmul
- Saxena, Romil
- He, Yong
- Guan, Yukun
- Feng, Dechun
- Sancho-Bru, Pau
- Zang, Mengwei
- Cameron, Andrew MacGregor
- Bataller, Ramon
- Tacke, Frank
- Sun, Zhaoli
- Liangpunsakul, Suthat
- Gao, Bin
- Venue
- Journal of Clinical Investigation
- Published
- 2022-07-15
- Volume
- 132
- Issue
- 14
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC9282929
- OpenAlex
- W4285385617
- Cited by
- 90
- References
- 57
- Citations by year
- 2026: 10 · 2025: 32 · 2024: 24 · 2023: 20 · 2022: 3
- FWCI
- 13.37
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Investigation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- IUScholarWorks (Indiana University) (submittedVersion, cc-by)
- Funders
- National Institutes of Health (Intramural program)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- severe alcoholic hepatitis, NCF1, reactive oxygen species, AMPK, miR-223, CD8+ T cells, liver inflammation, liver injury, liver failure, hepatic steatosis, liver fibrosis
- MeSH terms
- Ethanol, Animals, Hepatitis, Alcoholic, Inflammation, Liver, Liver Diseases, Alcoholic, Mice, Inbred C57BL, Phenotype, Reactive Oxygen Species, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.